Nur Benzonana

6.4k total citations
10 papers, 280 citations indexed

About

Nur Benzonana is a scholar working on Epidemiology, Infectious Diseases and Pharmacology. According to data from OpenAlex, Nur Benzonana has authored 10 papers receiving a total of 280 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Epidemiology, 3 papers in Infectious Diseases and 2 papers in Pharmacology. Recurrent topics in Nur Benzonana's work include Ocular Infections and Treatments (2 papers), Antibiotic Resistance in Bacteria (2 papers) and Bacillus and Francisella bacterial research (1 paper). Nur Benzonana is often cited by papers focused on Ocular Infections and Treatments (2 papers), Antibiotic Resistance in Bacteria (2 papers) and Bacillus and Francisella bacterial research (1 paper). Nur Benzonana collaborates with scholars based in Türkiye, France and Slovenia. Nur Benzonana's co-authors include Matthieu Revest, Asuman Orçun, Raymond Ruimy, Laurent Riffaud, Pierre Tattevin, Jean‐Marc Tadié, Romain Sonneville, Öznur Ak, Serdar Özer and Serap Gençer and has published in prestigious journals such as Journal of Antimicrobial Chemotherapy, Clinical Microbiology and Infection and BMJ Open.

In The Last Decade

Nur Benzonana

9 papers receiving 269 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nur Benzonana Türkiye 7 120 72 65 58 55 10 280
Jana Kolman Slovenia 11 166 1.4× 61 0.8× 63 1.0× 62 1.1× 133 2.4× 14 290
J. Grando France 10 121 1.0× 33 0.5× 50 0.8× 81 1.4× 123 2.2× 20 339
A. Seymour United Kingdom 11 192 1.6× 98 1.4× 66 1.0× 30 0.5× 70 1.3× 14 303
A.-M. Van den Abeele Belgium 11 229 1.9× 37 0.5× 86 1.3× 41 0.7× 80 1.5× 15 364
H. Salord France 11 70 0.6× 41 0.6× 109 1.7× 36 0.6× 57 1.0× 16 253
Camille d’Humières France 12 103 0.9× 72 1.0× 20 0.3× 91 1.6× 151 2.7× 24 331
Sujata Baveja India 9 107 0.9× 96 1.3× 16 0.2× 35 0.6× 134 2.4× 31 348
Silvia Hernáez Spain 10 151 1.3× 26 0.4× 20 0.3× 56 1.0× 63 1.1× 17 280
Tamar Gottesman Israel 9 69 0.6× 61 0.8× 31 0.5× 11 0.2× 86 1.6× 18 258
Kentaro Nagaoka Japan 10 103 0.9× 67 0.9× 27 0.4× 57 1.0× 98 1.8× 43 326

Countries citing papers authored by Nur Benzonana

Since Specialization
Citations

This map shows the geographic impact of Nur Benzonana's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nur Benzonana with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nur Benzonana more than expected).

Fields of papers citing papers by Nur Benzonana

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nur Benzonana. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nur Benzonana. The network helps show where Nur Benzonana may publish in the future.

Co-authorship network of co-authors of Nur Benzonana

This figure shows the co-authorship network connecting the top 25 collaborators of Nur Benzonana. A scholar is included among the top collaborators of Nur Benzonana based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nur Benzonana. Nur Benzonana is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Benzonana, Nur, et al.. (2021). Hyperbaric oxygen treatment for toxic epidermal necrolysis: A case report. Diving and Hyperbaric Medicine Journal. 51(2). 216–219.
2.
Sonneville, Romain, Raymond Ruimy, Nur Benzonana, et al.. (2017). An update on bacterial brain abscess in immunocompetent patients. Clinical Microbiology and Infection. 23(9). 614–620. 91 indexed citations
3.
Can, Füsun, Şirin Menekşe, Nazlı Ataç, et al.. (2017). Impact of the ST101 clone on fatality among patients with colistin-resistant Klebsiella pneumoniae infection. Journal of Antimicrobial Chemotherapy. 73(5). 1235–1241. 47 indexed citations
4.
Benzonana, Nur, et al.. (2013). Evaluation of soluble CD14 subtype (presepsin) in burn sepsis. Burns. 40(4). 664–669. 58 indexed citations
5.
Midilli, Kenan, et al.. (2013). Nosocomial outbreak of disseminated orf infection in a burn unit, Gaziantep, Turkey, October to December 2012. Eurosurveillance. 18(11). 20425–20425. 25 indexed citations
6.
7.
Ak, Öznur, et al.. (2012). Influenza B-associated encephalopathy in two adults. Journal of Infection and Chemotherapy. 18(6). 961–964. 12 indexed citations
8.
Özkurt, Yelda, et al.. (2006). Pseudallescheria boydii Keratitis. Journal of Pediatric Ophthalmology & Strabismus. 43(2). 114–115. 2 indexed citations
9.
Özkurt, Yelda, et al.. (2006). Pseudallescheria boydii Keratitis. Journal of Pediatric Ophthalmology & Strabismus. 43(2). 114–115. 3 indexed citations
10.
Gençer, Serap, Öznur Ak, Nur Benzonana, Ayşe Batırel, & Serdar Özer. (2002). Susceptibility patterns and cross resistances of antibiotics against Pseudomonas aeruginosa in a teaching hospital of Turkey. Annals of Clinical Microbiology and Antimicrobials. 1(1). 2–2. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026